e-learning
resources
London 2016
Tuesday, 06.09.2016
Mechanisms of disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
Kylie Belchamber (London, United Kingdom), Kylie Belchamber, Peter Barnes, Louise Donnelly
Source:
International Congress 2016 – Mechanisms of disease
Session:
Mechanisms of disease
Session type:
Poster Discussion
Number:
4657
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kylie Belchamber (London, United Kingdom), Kylie Belchamber, Peter Barnes, Louise Donnelly. Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages. Eur Respir J 2016; 48: Suppl. 60, 4657
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
NDP52 inhibition rescues cigarette smoke mediated impairment of autophagy in macrophages
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Oxidative stress drives defective efferocytosis in COPD M2-like macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Distinct localization of estrogen receptors in lungs of severe COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Characterization of M1 and M2 macrophages in human lung tissue
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Elevated GM-CSF in COPD may drive defective macrophage phenotype
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Impaired monocyte chemotaxis in COPD
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Differential cigarette smoke and H2O2 induced cytokine release from macrophages in COPD
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Monocyte sub-populations do not reflect differences in COPD macrophage phenotype
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Mitochondrial dysfunction in macrophages: a key to defective bacterial phagocytosis in COPD
Source: Eur Respir J, 54 (4) 1901641; 10.1183/13993003.01641-2019
Year: 2019
Hyperoxia impairs the inflammatory response of alveolar macrophages to multiple Toll-like receptor ligands associated with bacterial infection
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Identification of Ki67+ ’monocytic’ cells within the lungs
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept